CYTK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cytokinetics Inc

Watchlist Manager

Watchlist

Price: 63.295 USD -0.02% Market Closed

Market Cap: $8.6B

	Cytokinetics Inc NASDAQ:CYTK	US
	Iress Ltd ASX:IRE	AU
V	Vertex Pharmaceuticals Inc XHAM:VX1	US
	Latrobe Magnesium Ltd ASX:LMG	AU
	Equitable Holdings Inc F:AXJ	US
D	Diamondrock Hospitality Co NASDAQ:DRH	US
P	Powszechna Kasa Oszczednosci Bank Polski SA SWB:P9O	PL
C	Cleveland-Cliffs Inc F:CVA	US
	Renaissancere Holdings Ltd F:RRJ	BM
A	Adidas AG OTC:ADDDF	DE
	Intuit Inc NASDAQ:INTU	US
	Advantest Corp F:VANA	JP
	Newmark Security PLC LSE:NWT	UK
	Element Solutions Inc NYSE:ESI	US
E	Element Solutions Inc F:PLQ	US
	Barnes & Noble Education Inc F:2BN0	US
	Parrot SA PAR:PARRO	FR
F	FirstEnergy Corp SWB:FE7	US

Profitability Summary

Cytokinetics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Low 3Y Average Gross Margin

Negative Operating Margin

-1.225%

Negative 3Y Average Operating Margin

-5.642%

Operating Margin is Increasing

-6.340% > -1.225%

Negative Net Margin

-1.321%

Negative 3Y Average Net Margin

-6.124%

Net Margin is Increasing

-6.736% > -1.321%

Negative Free Cash Flow Margin

-858%

Negative 3Y Average Free Cash Flow Margin

-4.501%

Free Cash Flow Margin is Increasing

-5.665% > -858%

Exceptional ROE

330%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

714%

ROIC is Increasing

-260% > -152%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.